PDLIM7 and cervical cancer: EBNA-1 and LMP-1 in cervical cancer specimens, with the authors reporting a 22.2% prevalence in UCC patients. Tthe 1-year and 5-year OS rates were higher in the EBV-positive group compared to the EBV-negative group.